UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from_____ to_____ Commission File Number 0-16211 DENTSPLY SIRONA Inc. (Exact name of registrant as specified in its charter) (State or other jurisdiction of (I.R.S. Employer inc ...

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Q1 2022 Earnings Conference Call May 10, 2022 8:30 AM ET Company Participants Andrea Daley - VP, IR John Groetelaars - Interim CEO Barbara Bodem - CFO Conference Call Participants Elizabeth Anderson - Evercore Kevin Caliendo - UBS Jason Bednar - Piper Sandler Erin Wright - Morgan Stanley Jeff Johnson - Baird Jon Block - Stifel Matt Miksic - Credit Suisse Rachel Vatnsdal - JPMorgan Operator Welcome to the Dentsply Sirona First Quarter 2022 Results Conference Call. All parti ...

First Quarter 2022 Earnings Conference Call May 10, 2022 2 Forward-Looking Statements and Associated Risks All statements in this presentation that do not directly and exclusively relate to historical facts constitute "forward-looking statements." These statements represent current expectations and beliefs, and no assurance can be given that the results described in such statements will be achieved. Such statements are subject to numerous assumptions, risks, uncertainties and other factors that could cause ...

Financial Performance - Dentsply Sirona reported revenues of $4.25 billion for 2021, reflecting a 24.6% organic growth compared to 2020 and a 4.9% increase compared to 2019 [12][23] - For Q4 2021, revenue was $1.088 billion, with organic sales growth of 1.8% and reported growth of 0.6% [15] - The operating margin for 2021 was 20.5%, with adjusted EPS at $2.87, and operating cash flow of $657 million [12][28] Business Segment Performance - In Q4, technology and equipment organic sales grew by 6.5%, while consumables declined by 4.6% [19] - Clear aligners, implants, and CAD/CAM businesses showed strong growth despite supply chain challenges [15][19] - The full year 2021 saw clear aligners generating $270 million, with SureSmile exceeding the $100 million annual run rate goal [24] Market Performance - U.S. sales in Q4 were $385 million, with slight organic growth year-on-year, while European sales were $437 million with 1.8% organic growth [22] - The rest of the world sales reached $266 million, representing 4% organic growth, impacted by COVID restrictions in APAC, particularly China [22] Company Strategy and Industry Competition - The company aims for reliable 4% to 5% revenue growth, continuous margin improvement, and double-digit earnings growth [40] - Dentsply Sirona is focusing on digital dentistry, with significant investments in R&D and strategic collaborations, such as with Google Cloud [11][45] - The company is committed to enhancing its digital portfolio and improving operational efficiencies while navigating supply chain challenges [35][53] Management's Comments on Operating Environment and Future Outlook - Management acknowledged ongoing supply chain constraints and anticipated challenges for at least one or two quarters in 2022 [15][30] - The effective tax rate is expected to be between 23% and 24%, with EPS projected in the range of $3.05 to $3.25 for 2022 [31][31] - Management expressed confidence in the resilience of the dental market and the company's ability to expand revenue and earnings over time [36][56] Other Important Information - The company plans to return at least 50% of free cash flow to shareholders through dividends and share repurchases [35] - Dentsply Sirona is developing global standards for cleft treatment protocols and sponsoring the 2022 World Oral Health Campaign [37] Q&A Session Summary Question: Impact of Omicron on Q4 results and January performance - Management noted that December saw complications due to staffing shortages, leading to lower volumes, which continued into January, particularly in regions with strict COVID policies [60][61] Question: Commercial launch calendar for Primeprint - The global launch is expected towards the end of Q2, primarily in North America and Central Europe, with further details to be refined as the launch date approaches [63][66] Question: Supply chain disruptions and visibility on components - Management indicated that visibility into electronic component shortages is complicated, with expectations that issues may persist into the first half of the year [71][73] Question: Confidence in supply chain improvement in the second half - Management expressed cautious optimism based on supplier feedback and ongoing efforts to manage inventory levels [110] Question: Strategy regarding portfolio evolution - The company continues to evaluate its portfolio based on growth potential, margin accretion, and alignment with digital workflows, with no immediate plans for major divestitures [88]

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 Commission File Number 0-16211 DENTSPLY SIRONA Inc. (Exact name of registrant as specified in its charter) Delaware 39-1434669 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) 13320 Ballantyne Corporate Place, Charlotte, North Carolina 28277-3607 (Ad ...

Fourth Quarter 2021 Earnings and 2022 Outlook February 28, 2022 2 Forward-Looking Statements and Associated Risks All statements in this presentation that do not directly and exclusively relate to historical facts constitute "forward-looking statements." These statements represent current expectations and beliefs, and no assurance can be given that the results described in such statements will be achieved. Such statements are subject to numerous assumptions, risks, uncertainties and other factors that could ...

Third Quarter 2021 Earnings Conference Call 1 November 4, 2021 Don Casey CEO Jorge Gomez EVP & CFO 2 Forward-Looking Statements and Associated Risks All statements in this presentation that do not directly and exclusively relate to historical facts constitute "forward-looking statements." These statements represent current expectations and beliefs, and no assurance can be given that the results described in such statements will be achieved. Such statements are subject to numerous assumptions, risks, uncerta ...

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Q3 2021 Earnings Conference Call November 4, 2021 8:30 AM ET Company Participants Don Casey – CEO Andrea Daley – VP Investor Relations Jorge Gomez – CFO Conference Call Participants Elizabeth Anderson – Evercore Tycho Peterson – JP Morgan Tom Stephan – Stifel Jeff Johnson – Baird Korinne Wolfmeyer – Piper Sandler Justin Lane – William Blair Allen Lutz – Bank of America Nathan Rich – Goldman Sachs Operator Good day everyone and welcome to the Q3 2021, Dentsply Sirona Earnin ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 Commission File Number 0-16211 DENTSPLY SIRONA Inc. (Exact name of registrant as specified in its charter) (State or other jurisdiction of (I.R.S. Employer incorporation or organization) Identification No.) Delaware 39-1434669 13320 Ballantyne Corporate Place, Charlotte, North Carolina 28277 ...

Dentsply Sirona Inc. (NASDAQ:XRAY) Q2 2021 Results Conference Call August 5, 2021 8:30 AM ET Company Participants Andrea Daley - Head, Investor Relations Don Casey - Chief Executive Officer Jorge Gomez - Executive Vice President and Chief Financial Officer Conference Call Participants Elizabeth Anderson - Evercore Jeff Johnson - Baird Tycho Peterson - JPMorgan Nathan Rich - Goldman Sachs Korinne Wolfmeyer - Piper Sandler Allen Lutz - Bank of America Lisa Garcia - Wolfe Research Operator Good day. Thank you ...